revealed in patients as a result of altered responses to xenobiotic exposure, including therapeutic drugs.
Reporting on three patients with congenital adrenal hyperplasia, Arlt et al. (2004) found altered urinary sterol profiles indicative of combined CYP17 and CYP21 deficiencies but no mutations in either CYP gene, leading them to pursue POR genetics. Two of the patients had a 531T3 G mutation in POR exon 5, encoding a CYPOR Y181D substitution. In the same study, a bacterially expressed Y181D protein, lacking 46 N-terminal residues, was devoid of measurable NADPH-cytochrome c reductase (NCR) activity. The capacity of heterologously expressed CYPOR Y181D to support mitomycin Cinduced apoptosis in a cell culture model was further shown to be completely diminished compared with wild-type (WT) CYPOR (Wang et al., 2007) .
Bacterial membranes, containing human CYPOR Y181D (truncated by 27 N-terminal residues), were devoid of detectable NCR activity and were unable to support 17 ␣-hydroxylase and 17,20 lyase activities of CYP17A1 (Huang et al., 2005) . Likewise, CYP1A2 and CYP2C19 activities were not supported by Y181D (Agrawal et al., 2008) . Shen et al. (1989) previously characterized the orthologous Y178D variant of rat liver CYPOR using a bacterially expressed construct. FMN incorporation and NCR activity were both abolished by the mutation. A maximum of ϳ17% of WT NCR activity could be restored on addition of FMN, with half-maximal activation achieved at [FMN] ϭ 3.4 M.
The structure of the full cytosolic catalytic domain of rat CYPOR (Wang et al., 1997) , as well as that of the FMN binding domain of human CYPOR (Zhao et al., 1999) , shows that in the WT enzyme, Y181 forms stacking interactions with the si-face of FMN (Fig. 1) . Substitution of the tyrosyl phenol with the carboxylic acid side chain of aspartate would remove a large hydrophobic surface interaction and introduce a strong negative charge to the FMN binding site with deleterious implications for FMN incorporation, oxidation/reduction cycling, and docking interactions with acidic surface residues of microsomal electron acceptors.
Recently solved crystal structures of a modified rat CYPOR variant (Hamdane et al., 2009 ) and of a yeast-human CYPOR chimera (Aigrain et al., 2009 ) have provided evidence for a mechanistic domain rearrangement, described as the "open-closed" transition, whereby the NADPH/FAD binding domain, held in close proximity to the membrane-anchored FMN binding domain in the closed state, moves up to ϳ90 Å away in the open state, subsequently exposing FMN to interactions with a multitude of microsomal electron-accepting protein partners. Although specific amino acids within the hinge region of the connecting domain have been implicated by deletion [⌬T 236 -E 239 ] (Hamdane et al., 2009 ), the mechanisms triggering or actuating conformational dynamics are currently unresolved. The hypothesis of the conformational change driven by redox states of FAD and FMN, as well as by NADPH occupancy, necessitates a role for FMN with which Y181D substitution would likely interfere.
Here, we have characterized the deleterious nature of the Y181D mutation using purified human CYPOR combined with a bacterial model of the membrane-localized CYPOR-CYP1A2 functional interaction. The extent to which FMN binding is compromised by the mutation and rescue of function is described as a possible indication for therapeutic modalities.
Materials and Methods
Site-Directed Mutagenesis. The construction of bacterial expression plasmids encoding OmpA3-fused, full-length human CYPOR (holo) and N-terminally truncated human CYPOR (⌬66), as well as the methods used to mutagenize them, have been described in detail previously (Marohnic et al., 2006) . The oligonucleotides used to insert the 531T3 G substitution, encoding Y181D, were as follows: (sense) 5Ј-ggg aac aag acc gat gag cac ttc aat gcc-3Ј and (antisense) 5Ј-ggc att gaa gtg ctc atc ggt ctt gtt ccc-3Ј.
Protein Expression and Purification. Histidine-tagged, soluble ⌬66 CY-POR proteins were bacterially expressed and purified as described previously (Marohnic et al., 2006) . Membrane-bound CYPOR proteins were also expressed, detergent-extracted, and 2Ј5ЈADP-Sepharose 4B (GE Healthcare, Uppsala, Sweden) affinity-purified as described previously (Marohnic et al., 2006; Huber et al., 2009 ). The purity of each preparation was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). Fractions exhibiting singleband purity were pooled and concentrated (Centriprep 30; Millipore Corporation, Billerica, MA) before quantification by oxidized flavin absorbance (total flavin 454 nm ϭ 21.4 mM Ϫ1 cm Ϫ1 ) and by the micro-bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL) according to standard protocol. Aliquots were stored under liquid N 2 .
Flavin Content Analysis. Flavins were extracted into water from 50 M protein samples by boiling for 5 min. Boiled samples were immediately chilled on ice before centrifugation at 14,000g for 10 min to precipitate aggregated protein. Samples were then diluted 5-fold in mobile phase before high-performance liquid chromatography (HPLC) analysis using a Hewlett-Packard (Palo Alto, CA) Series 1100 HPLC equipped with a G1316A diode-array detector. A Thermo Fisher Scientific (Waltham, MA) Hypersil Gold column (150 ϫ 2.1 mm, 5 m) was fitted with a guard column packed with Nova-Pak C18 Guard-Pak inserts (Waters, Milford, MA). The column was equilibrated with the mobile phase buffer (filtered and degassed) consisting of 94% 10 mM (NH 4 ) 2 HPO 4 , pH 5.5, and 6% acetonitrile. The flow rate was 0.75 ml/min, and flavins were monitored at 473 nm with FAD ϭ 10.1 mM
. Extinction coefficients were determined by measurement of standards contained in the mobile phase buffer. Integration and analysis were performed using Agilent Technologies (Santa Clara, CA) ChemStation software (Rev. B.03.02).
Spectroscopic Analysis. UV/visible absorbance spectra ( ϭ 250 -900 nm) were recorded using an Agilent Technologies 8453 diode-array spectrophotometer. Circular dichroism (CD) spectra were recorded in the far UV ( ϭ 180 -300 nm) and near UV/visible ( ϭ 300 -600 nm) regions using a Jasco (Easton, MD) J815 spectropolarimeter. Far UV measurements were made of 0.7 M protein samples contained in 50 mM KPi, pH 7.0, in a quartz cylindrical cuvette with a path length of 0.1 cm. Near UV/visible measurements were made of 30 M protein samples contained in 50 mM MOPS, pH 7.0, in a quartz cylindrical cuvette with a path length of 1.0 cm. (Wang et al., 1997) , rendered in gray] with that of human CYPOR [Protein Data Bank ϭ 1b1c (Zhao et al., 1999) , rendered in blue] with root mean square deviation ϭ 0.27 Å. Human residue Y143, in green (orthologous rat Y140 in cyan), is positioned behind the re-face of FMN. Human Y181, in red (orthologous rat Y178 in magenta), forms a stacking interaction with the si-face of FMN. Figure was Fluorometric Analysis of FMN Binding. FMN fluorescence quenching on equilibrium binding to Y181D ⌬66 protein was measured as described previously (Vermilion and Coon, 1978 ) using a Horiba Jobin Yvon (Edison, NJ) FluoroMax-3 with ex ϭ 450 nm and em ϭ 530 nm, with a 100-ms integration time in antibleaching mode. At constant [enzyme] , measurements were carried out while titrating a 2-ml sample in 50 mM KPi, pH 7.4, and 0.5 mM EDTA with FMN from 0 to 50 M. After measurement of OD ex and OD em at each point in the titration, inner filter effects were corrected as described by Lakowicz (2006) . A further correction was applied for dilution factor before plotting F corr versus [FMN] . The difference in F corr in the presence and absence of enzyme, ⌬F, was plotted versus [FMN] . The resulting data were fitted to a single binding-site hyperbola using SigmaPlot (Systat Software, Inc., San Jose, CA) to estimate K d .
Kinetic Analysis of Purified CYPOR Variants. 1) NADPH-ferricyanide reductase (NFR) measurements were made in triplicate in 96-well format using a VERSAmax microplate reader (Molecular Devices, Sunnyvale, CA). Ferricyanide reduction was measured as the rate of decrease in absorbance at 420 nm using the extinction coefficient, 420 nm ϭ 1.02 mM Ϫ1 cm Ϫ1 with [ferricyanide] ϭ 1 mM. The reaction was contained in 50 mM KPi buffer, pH 7.0, [CYPOR] ϭ 10 nM. [NADPH] was varied over a range from 0.1 to 200 M. An NADPH-regenerating system was used, which consisted of 10 mM isocitrate, 0.5 units of isocitrate dehydrogenase, and 5 mM MgCl 2 . Reactions were monitored for 5 min, and rates were extrapolated from the linear range of the kinetic traces. Plots of rate versus NADPH concentration were fitted to the Michaelis-Menten equation, using SigmaPlot (Systat Software, Inc.), to determine k cat and K m values. 2) NCR activity was measured as described previously (Marohnic et al., 2006) .
Construction of MK_1A2_POR Cell Models. Coexpression of CYPOR variants with CYP1A2 in the BMX100-derived MK_1A2_POR strain of Escherichia coli was achieved using a biplasmid system described previously (Kranendonk et al., 1999) . Plasmid pLCM_POR contained human WT POR cDNA, based on National Center for Biotechnology Information sequence NM_000941, encoding the CYPOR consensus sequence NP_000932, lacking the first three amino acids. This plasmid was modified to contain the mutagenized Y181D allele or no cDNA [plasmid pLCM (Kranendonk et al., 1998) ]. The three plasmids were transfected into strain MK_1A2, already containing pCWhCYP1A2, the expression plasmid for human CYP1A2 (Fisher et al., 1992; Kranendonk et al., 1998) , yielding the humanized bacterial cell models MK_1A2_POR WT , MK_1A2_POR
Y181D , and MK_1A2_POR Null , respectively. Culture and induction conditions, as well as membrane preparation procedures, were the same as reported previously (Kranendonk et al., 2008) . CYP1A2 and CYPOR expression were quantified by reduced COdifference spectroscopy and immunoblotting, respectively, also as previously reported (Kranendonk et al., 2008) , substituting a monoclonal primary antibody to human CYPOR (Santa Cruz product sc-55477; Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
MK_1A2_POR Enzyme Activities. NCR activity of the membranes was determined as described before (Kranendonk et al., 2008) . Where indicated, FMN was added to a final concentration of 10 M, before starting the reaction with NADPH. Activities are reported as the mean Ϯ S.D. of triplicate determinations.
CYP1A2-mediated ethoxyresorufin-O-dealkylase (EROD) activity of membrane preparations was determined using the method described by Burke et al. (1994) in microplate format. Two types of EROD assays were performed, varying the ethoxyresorufin concentration (Յ5 M) either in the absence or presence of 10 M FMN or varying the FMN concentrations with fixed ethoxyresorufin concentration (2.5 M). The solvent dimethyl sulfoxide concentration was maintained at 0.2% (v/v) throughout. k cat and K m were extrapolated from a plot of the mean Ϯ S.D., determined in triplicate, of reaction rate versus ethoxyresorufin concentration according to the Michaelis-Menten equation.
MK_1A2_POR Mutagenicity Assays. Whole cell mutagenicity assays were performed as described previously (Kranendonk et al., 2008) . CYP1A2-mediated bioactivation is expressed in terms of mutagenic activity [L-arginine prototrophic (revertant) colonies per nanomole of compound or in revertant colonies per micromole of compound]. Mutagenicity values were determined from the linear portion of the dose-response curve, with each dose tested at least in triplicate.
Statistical Analysis. Statistical analysis was performed by applying the Student's t test, using GraphPad Software Inc. (San Diego, CA) software.
Results
Characterization of Purified CYPOR Variants. WT human CYPOR, as well as the mutated Y181D variant, was bacterially expressed and purified in both soluble (⌬66) and membrane anchorcontaining (holo) isoforms. Each of the purified enzymes exhibited the predicted molecular mass on SDS-PAGE of 72 kDa for ⌬66 and 77 kDa for holo (Supplemental Fig. 1 ).
Both WT isoforms, when purified, were green because of the protein-bound content of oxidized FAD (yellow) and air-stable FMN semiquinone (blue). In contrast, both Y181D isoforms were bright yellow on purification, suggesting either altered flavin content or flavin oxidation/reduction potentials. Representative ⌬66 UV/visible spectra are shown in Supplemental Fig. 2 . The visible fingerprint of air-stable neutral blue FMN semiquinone, a broad peak at approximately 600 nm, was apparent for WT but not for Y181D.
The concentration of each protein preparation was determined both as a function of oxidized flavin absorbance and by the micro-BCA assay (Pierce). Both methods yielded similar results for WT ⌬66 (2.0 Ϯ 0.2 mol flavin/mol protein) and holo (2.1 Ϯ 0.2 mol flavin/mol protein) samples, indicating complete cofactor incorporation. Concentrations based on flavin absorbance were at least 2-fold lower than the corresponding values obtained by micro-BCA for Y181D samples with molar flavin/protein ratios of 1.0 Ϯ 0.2 for Y181D ⌬66 and 1.1 Ϯ 0.2 for Y181D holo. These results suggested that Y181D proteins, as purified, were deficient in flavin.
Therefore, HPLC-based measurements of flavin content were performed (Fig. 2 ). FAD and FMN standards had retention times of ϳ4.7 and ϳ7.2 min, respectively. WT ⌬66 exhibited the full complement of both FAD and FMN at a 1:1 ratio. Depending on the batch of protein tested, volume of buffers used in purification, and extent of postpurification dialysis, Y181D ⌬66 had FMN content ranging from Ͻ1% up to nearly 10% of protein concentration but contained nearly the full complement of FAD (ϳ95% of protein concentration). In previous studies of FAD-deficient ⌬66 CYPOR mutants (Y459H and V492E), overnight incubation with excess FAD resulted in increased FAD/ protein ratios (Marohnic et al., 2006) . In contrast, overnight incubation of Y181D ⌬66 with 100-fold molar excess of FMN, followed by separation of protein-bound and free flavins by gel filtration, yielded no measureable increase in protein-bound FMN content (data not shown), showing the strong contribution of FMN concentration to the equilibrium between FMN binding and dissociation from the Y181D-substituted protein. Considering the relatively small number of molecular contacts between CYPOR and FMN (compared with the CYPOR-FAD interaction), the loss of key hydrophobic/aromatic surface interactions between the phenol side-chain atoms of Y181 and the FMN isoalloxazine ring, as well as the introduction of a negatively charged carboxylic acid by substitution with aspartate, diminished the stability of the CYPOR-FMN interaction.
CD spectra were collected for each of the ⌬66 samples in the both the far-UV (Fig. 3A) and near-UV/visible (Fig. 3B) regions. Comparison of WT and Y181D far-UV CD spectra suggested that Y181D substitution had no major effect on protein secondary structure. However, the absence of protein-bound FMN in the Y181D variant became apparent on comparison of near-UV/visible CD spectra of the ⌬66 samples. WT CYPOR had negative CD bands centered at approximately 360 and 450 nm, indicative of flavin structural conformation and microenvironment polarity, with the strongly negative character of protein-bound FMN canceling out the positive character contributed by protein-bound FAD in the band at approximately 360 nm. The Y181D spectrum had a strong positive band centered at 375 nm, verifying the presence of bound FAD, but the negative band at approximately 450 nm (attributable to bound FMN) was weakened. Addition of 60 M (2 ϫ [protein]) FMN to the WT sample had a small additive effect on the spectrum, contributing positive character at approximately 325 nm. In contrast, addition of 60 M FMN to the Y181D sample had a more dramatic effect, causing the spectrum to more closely resemble that of WT, with dual negative bands at 375 and 460 nm, presumably a result of FMN binding to the apoprotein. This finding contrasted with the previous observation that overnight treatment of Y181D with saturating FMN, followed by separation of bound/free flavins by size exclusion, yielded no observable increase in protein-bound FMN content. Taken together, these results emphasize the contribution of [FMN] to the equilibrium involving FMN association/dissociation within the Y181D protein.
Binding to CYPOR, as well as many other proteins, has been shown to quench the fluorescence of FMN as a result of stacking interactions with aromatic residues. Titrations of buffer and Y181D ⌬66 were performed with increasing concentrations of FMN. After corrections for dilution and inner filter effects, FMN fluorescence (F corr ) and [FMN] displayed linear proportionality in buffer alone (Fig. 4A) . When the titration was repeated in the presence of 10 M Y181D ⌬66 (Fig. 4A) , the correlation between F corr and [FMN] was a smooth dose-dependent curve. The difference in F corr Ϯ protein (FMN fluorescence quenching or ⌬F) was plotted versus [FMN] (Fig. 4B) , yielding a saturation curve with apparent K d ϭ 7.3 Ϯ 1.1 M. This value represented a ϳ560-fold increase compared with 13 nM, the value determined by Vermilion and Coon (1978) using the same method, and WT rat liver CYPOR, depleted of FMN by denaturation and refolding.
Having established the diminished capacity of purified Y181D ⌬66 protein to maintain bound FMN, the catalytic effects of FMN deficiency were assayed. NFR activity was measured for WT and Y181D, both in the presence and absence of exogenous FMN (added to the reaction at 1000-fold molar excess). Michaelis-Menten parameters for both holo and ⌬66 isoforms are reported in Table 1 . Y181D ⌬66 retained 80% of WT ⌬66 NFR turnover (1980 min Ϫ1 ) in the absence of added FMN, confirming previous observations in CYPOR that ferricyanide reductase activity is localized within the FAD domain (Vermilion and Coon, 1978) . The Y181D ⌬66 variant also exhibited a similar K m NADPH to WT ⌬66, with respective values of 3.4 and 4.6 M. Although both k cat and K m NADPH of WT ⌬66 were affected by FMN, the catalytic efficiency (k cat /K m ) was not. In the Y181D ⌬66 reaction, FMN addition decreased k cat (34%) with no significant effect on K m NADPH . Among the holo isoforms, addition of FMN consistently decreased NFR activity without affecting NADPH utilization. With the exception of the WT ⌬66 studies, these results suggested that FMN had an inhibitory effect that was not competitive with NADPH. Therefore, FMN was hypothesized to be acting as an electronaccepting substrate for both WT and Y181D ⌬66 variants. In a preliminary study, reduction of a 20 M solution of FMN was monitored at 446 nm under conditions of saturating NADPH (200 M) in a cuvette open to the atmosphere. No activity was observed for either WT or Y181D regardless of enzyme concentration (up to 1 M). Although it appeared from these studies that FMN was not acting as a substrate, NADPH consumption (at 340 nm) revealed that electron transfer was occurring, albeit slowly. WT was turning over NADPH at a rate of 4.6 Ϯ 0.4 min Ϫ1 and Y181D at 5.9 Ϯ 0.6 min Ϫ1 . When the same reactions were measured in the absence of FMN, those rates decreased 6-fold (0.8 Ϯ 0.2 min Ϫ1 ) for WT and 8-fold (0.7 Ϯ 0.3 min Ϫ1 ) for Y181D. Based on these results, it was hypothesized that FMN was acting to promote NADPH oxidase activity in both WT and Y181D. When the same experiments were repeated under semianaerobic conditions in a sealed cuvette in buffer that had been partially scrubbed of oxygen, FMN reduction was observed after a short lag period, during which NADPH was consumed at the usual rate. On complete reduction of FMN, NADPH consumption also stopped. Leaving FMN out of the reaction mixture had the same effect under semianaerobic conditions as it did under aerobic conditions, the only difference being the excursion of NADPH consumption. FAD had an identical effect on both WT and Y181D. Cumulatively, these studies showed that free flavins promoted low levels of NADPH oxidase activity by purified CYPOR.
Having shown that NFR function was retained by the Y181D variant, despite the absence of FMN, the thermal stability of the WT and Y181D ⌬66 isoforms was evaluated by measurement of residual NFR activity after incubation of aliquots for 5 min at temperatures ranging from 10 to 100°C (Supplemental Fig. 3 ). The profiles of the two proteins were nearly indistinguishable with loss of 50% of NFR activity occurring between 48 and 52°C. NCR activity, known for CYPOR to require protein-bound FMN, was also determined for both WT and Y181D variants. MichaelisMenten parameters are reported in Table 1 . WT ⌬66 exhibited a k cat /K m NADPH ϭ 220 min Ϫ1 M Ϫ1 , whereas WT holo was nearly three times more efficient with a k cat /K m NADPH ϭ 650 min Ϫ1 M Ϫ1 . Reaction rates were beneath the limit of detection when either ⌬66 or holo Y181D was assayed, in agreement with previously published findings using bacterially expressed, N-truncated proteins Huang et al., 2005; Wang et al., 2007) . On the other hand, purified Y181D was shown by HPLC to retain a small proportion of bound FMN, which would hypothetically confer at least some small amount of NCR activity. However, the assay required large dilution of the purified enzymes before activity measurements, and fluorometric studies suggested that dilution would favor dissociation of FMN from the Y181D ⌬66 protein. Addition of a 1000-fold molar excess of FMN to the reactions restored NCR activity to both Y181D isoforms. With a k cat ϭ 420 min Ϫ1 and K m NADPH ϭ 1.2 M, the FMNstimulated Y181D ⌬66 gained 53% of WT turnover and 159% of WT catalytic efficiency. Y181D holo was likewise activated by the addition of FMN with a catalytic efficiency of 290 min Ϫ1 M Ϫ1 , 45% that of WT holo. Addition of FMN to WT NCR assays had an inhibitory effect (ϳ20%).
To verify FMN K d determination from fluorescent methods, saturation of NCR activity by FMN titration was measured for WT and Y181D ⌬66 variants. The resulting titration curves are presented in Fig. 5 . The WT enzyme was not significantly affected by FMN titration; therefore, no K d could be determined. Using a single binding site model, the data for Y181D gave an apparent K d FMN ϭ 2.1 Ϯ 0.6 M. This value was 3.5-fold lower than was determined from fluorometric studies but still represented an approximate 160-fold increase over the 13 nM reported for WT rat liver CYPOR (Vermilion and Coon, 1978) .
Expression of Human CYP1A2 with Variant POR Alleles in MK_1A2_POR Cell Models. The soluble catalytic domains of CYPOR and microsomal P450s, produced using truncated con- FIG. 5 . FMN dependence of NCR activity of purified ⌬66 CYPOR variants: reaction rates of ⌬66 WT (O) and Y181D (---) were determined in triplicate. Error bars represent ϩ S.D. Estimates of K d FMN were made by fitting the data to a single binding site hyperbolic function using SigmaPlot (Systat Software, Inc.). Fitting parameters are reported in the inset; "no fit" means hyperbolic fitting did not converge such that K d FMN was not determined.
TABLE 1

Michaelis-Menten kinetic parameters for purified CYPOR variants
Twenty micromolar added to ϩFMN reactions. dmd.aspetjournals.org structs, are generally compromised in the ability to interact productively (Black et al., 1979) . For productive alignment of the two proteins, insertion of both proteins in an appropriate lipid microenvironment is considered essential (Hlavica et al., 2003) . Therefore, to test the effect of the Y181D POR mutation on P450 activity, we made use of the bacterial cell model MK1A2_POR, containing CYP1A2 and CYPOR correctly inserted into the membrane. Initially, MK_1A2_POR cell models were characterized with respect to CYPOR and CYP1A2 expression. Membrane fractions were derived from MK_1A2_POR WT , MK_1A2_POR Y181D , and MK_1A2_POR
null strains, and expression levels were evaluated (Table 2 ). CYP1A2 expression, measured by reduced CO difference spectra, ranged from 64 to 129 pmol/mg protein, values that represent contents normally obtained for CYP1A2 in this cell model (Kranendonk et al., 2008) . CYPOR expression levels were verified by SDS-PAGE analysis (Supplemental Fig. 4A) , with a 77 kDa CYPOR band present in WT and Y181D strains but absent from the null strain. CYPOR expression was confirmed by immunoblotting with a monoclonal antibody directed against the Nterminal region of human CYPOR (Supplemental Fig. 4B ). CYPOR protein levels were equal in the WT and Y181D strains and undetectable in the null strain. This indicated that Y181D substitution was not detrimental to CYPOR expression or stability in the MK_1A2 cell model.
In the absence of added FMN, membranes prepared from the Y181D strain showed only slightly higher NCR activity than those prepared from the null strain (Table 2) . If background activity (CYPOR-nonspecific, as indicated in the null strain) was subtracted from both WT and Y181D activities, the Y181D strain retained only ϳ3% WT NCR activity. This low level of NCR activity suggested that Y181D, when membrane-bound and not subjected to extensive washing during preparation, may have retained somewhat more FMN than purified Y181D proteins, although direct determination of CYPOR-specific flavin contents of the membranes was not made. On addition of FMN, the NCR activity of Y181D-containing membranes increased more than 15-fold, confirming that the observed FMN deficiency and activation of Y181D CYPOR were not unique to the purified enzymes.
The apparent FMN affinity of the Y181D variant, as derived from a single-binding site saturation plot of NCR activity versus [FMN] (Fig. 6A) , was 1.6 M, in good agreement with the value derived for the purified ⌬66 preparation (2.1 M).
Effect of the Y181D POR Mutation on CYP1A2 Activity in Membranes. The effect of the Y181D substitution on CYPOR interaction with one of its natural redox partners, CYP1A2, was tested using MK_1A2_POR membrane preparations. Having established that CYP/CYPOR ratios in the WT-and Y181D-containing membranes were similar and in the physiologically relevant range of ϳ12:1 (Table 2) , EROD activity was measured ( (Duarte et al., 2005a ). This activity is in contrast to the MK_1A2_POR Y181D membranes, which showed no activity. When the same EROD assays were performed in the presence of 10 M FMN, the activity of the WT-containing membranes was decreased by 10%. This activity was consistent with the apparent inhibitory effect of free FMN on the NFR and NCR activities of the purified WT proteins. Y181D-containing membranes exhibited a large increase in activity, recovering 41% of WT activity with k cat ϭ 0.24 min Ϫ1 and K m ethoxyresorufin ϭ 1.08 M. To estimate the functional FMN affinity of Y181D in the EROD assay, titrations were performed over the range from 0 to 100 M (Fig. 6B) . The data again fit well to a one-site binding model with an activation constant ϭ 1.16 M, corroborating our values determined by the NCR assay of the MK_1A2_POR Y181D membranes and purified ⌬66 Y181D protein.
Effect of Y181D Allele on Whole-Cell Bioactivation of Procarcinogens.
To evaluate the effects of the Y181D POR mutation on xenobiotic metabolism, we made use of a whole cell mutagenicity assay using the MK_1A2_POR strain, as described previously for BTC1A2_POR bacteria (Duarte et al., 2005b; Kranendonk et al., 2008) . The frequency of mutagenic reversion of arginine auxotrophy was measured in response to exposure of the bacteria to three well characterized CYP1A2-activated procarcinogens, namely, 2-aminoanthracene (2AA), 2-amino-3-methylimidazo(4,5-f)quinoline (IQ), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), (Fig. 7) . The compound 2AA was highly mutagenic to the MK_1A2_POR WT cells but also had a strong effect on the MK_1A2_POR Y181D and MK_1A2_POR null cells. IQ was also efficiently bioactivated by MK_1A2_POR
WT cells, whereas MK_1A2_POR Y181D and MK_1A2_POR null cells showed only 23 and 7% of the mutagenicity level of the POR WT for this compound, respectively. The mutagenic activity of 2AA and IQ in the null strain was observed previously (Kranendonk et al., 2008) and is thought to stem from substrate-induced differential reduction of CYP1A2 by endogenous bacterial redox partners, such as flavodoxins. The same phenomenon also occurs in strains expressing functionally deficient CYPOR variants, such as Y459H and V492E, as described previously (Kranendonk et al., 2008) , and Y181D. Only MK_1A2_POR
WT cells were able to bioactivate NNK, the CYP1A2-mediated bioactivation of which seems to be particularly dependent on the presence of a fully active CYPOR (Kranendonk et al., 2008) .
Discussion
A number of studies, including the original from Arlt et al. (2004) detailing the discovery of the exon 5 POR 541T3 G mutation, have shown the catalytic incompetence of Y181D-substituted CYPOR using various assays and means of recombinant protein expression (Huang et al., 2005; Wang et al., 2007; Agrawal et al., 2008) . Before the discovery of POR deficiency as a cause of human disease, Shen et al. (1989) showed that the orthologous Y178D variant of rat CYPOR, recombinantly expressed and purified, was unable to catalyze NCR activity because of loss of FMN. Since their report, the crystal structure of the rat CYPOR has shown the role of Y178 (corresponding to human Y181) as a stacking residue in the binding of FMN (Wang et al., 1997) . Here, both purified and membrane-associated Y181D models were used to confirm and analyze, in more detail, compromised FMN binding as the specific molecular defect leading to multiple microsomal P450 deficiencies.
Data reported here show that FMN binding by human CYPOR is severely compromised as a result of Y181D substitution. Y181D protein, as purified, retained NFR activity because NADPH and FAD binding sites were unperturbed. The far-UV CD spectrum of the Y181D protein was consistent with proper folding. Thermal stability was likewise unaffected by the Y181D substitution (supplemental data).
The lack of air-stable semiquinone on purification and low flavin/ protein ratio provided indirect evidence of FMN deficiency in Y181D samples. The degree to which FMN binding was compromised was shown directly by HPLC. Depending on the stringency of column washes and dialysis, the FMN content of the purified samples ranged from Ͻ1% up to 10%. These observations provided evidence that the equilibrium of FMN association/dissociation was not only shifted toward dissociation by the Y181D substitution but also that the process was highly dependent on the concentration of FMN present in solution. Accounting for extensive dilutions, such as those typically used to achieve catalytic enzyme concentrations for steady-state assays, it was not surprising that FMN association would diminish, along with FMN-dependent activity, in Y181D preparations. This weak FMN binding was consistent with the total lack of measurable NCR activity in previous studies and in the purified Y181D protein samples, as well as the very low levels in membranes prepared from MK_1A2_POR Y181D cells. In the context of living bacterial cells, the membrane-bound holo Y181D variant again exhibited diminished activity. Support of CYP1A2-mediated procarcinogen metabolism in the MK_1A2_POR model varied depending on the compound being tested. In all cases, a significant decrease was observed for the Y181D containing strain compared with WT.
Beyond confirmation that FMN binding was compromised by the mutation, these studies were designed to address restoration of CYPOR enzymatic function by reconstitution with FMN, as was previously observed by Shen et al. (1989) in studies in which rat Y178D function was partially restored (17% compared with WT) with an apparent K d FMN ϭ 3.4 M. By comparison, FMN addition restored NCR activity of the human CYPOR tested here to a greater extent: Y181D ⌬66 to 64% of WT ⌬66, Y181D holo to 33% of WT holo, and MK_1A2_POR Y181D membranes to 74% of MK_1A2_POR WT membranes. The structural basis for the observed difference in FMN functional restoration of NCR activity between rat and human CYPORs is not apparent, considering the high degree of similarity between the two structures (Fig. 1) . In the CYP1A2-mediated EROD assay, ϳ37% of the activity of 
MK_1A2_POR
WT membranes was restored to MK_1A2_POR Y181D membranes by FMN addition. These data suggest that a high level of electron transfer activity may be gained when FMN is delivered to the Y181D variant of human CYPOR. It remains to be tested whether a dietary or pharmaceutical regimen could achieve that desired effect in vivo.
FMN binding to purified Y181D ⌬66, when measured as a function of FMN fluorescence quenching, was found to occur with an apparent K d ϭ 7.3 M. When restored NCR activity was the measure of FMN binding to Y181D ⌬66, a K d ϭ 2.1 M was determined. The observed K d values, although in relative agreement, can be attributed to the differences in the requirement for stable versus catalytically productive FMN binding. A short-lived interaction with FMN is apparently sufficient to restore NCR and CYP1A2-mediated EROD function to the enzyme but is apparently insufficient to achieve quenched fluorescence, where more sustained binding interactions are required to achieve measurable saturation.
When the FMN dependence of NCR and CYP1A2-catalyzed EROD activities of MK_1A2_POR Y181D were measured, K d values of 1.6 and 1.16 M were determined, respectively. These lower activation/binding constants likely reflect a role for membrane incorporation of CYPOR in FMN binding and utilization. It would also be consistent to hypothesize that as the number of slower steps in the catalytic mechanism increases (EROD turnover being much slower than NCR), the half-life of the FMN-CYPOR complex makes less of a contribution to the rate of reaction. On the other hand, if FMN binding is required to sense or initiate domain rearrangement of CYPOR from the closed to open conformation to facilitate P450 binding and electron transfer, as described recently (Aigrain et al., 2009; Hamdane et al., 2009) , then Y181D substitution and the subsequent lack of FMN affinity would be expected to influence more negatively the structurally dynamic CYPOR-P450 interaction than interactions between CYPOR and artificial electron acceptors that do not theoretically require FMN domain movement (NCR). That NCR activity of MK_1A2_POR Y181D was restored by FMN addition to 74% of MK_1A2_POR WT , whereas the EROD activity of MK_1A2_POR Y181D was restored only to 36% of MK_1A2_POR
WT is consistent with that hypothesis, although further evidence is required to define the role of FMN in CYPOR domain rearrangement, as well as the role of domain rearrangement in the overall catalytic mechanism of the enzyme.
Whether purified or left intact in a membrane environment, the Y181D variant of CYPOR exhibited several hundred-fold reduced affinity for FMN compared with WT. A composite perspective of the results of FMN binding/utilization studies of Y181D suggests a K d between 1 and 8 M, a range that is incompatible with in vivo flavinylation, where estimates of cytosolic FMN concentration vary by tissue and cell type but, under normal conditions, are not thought to exceed ϳ50 nM (that of circulating erythrocytes) (Hustad et al., 2002) .
Relationships between riboflavin, FMN, and FAD in health and nutrition have been reviewed extensively (Powers, 2003) . Riboflavin and FAD, and FMN to a lesser extent, are normally absorbed from the diet, where in the serum, flavins have been shown to associate with albumin and globulins. Pregnancy-specific flavin-binding proteins, involved in delivery of flavins across the placenta, are essential to fetal development (Seshagiri and Adiga, 1987) . Low-dose riboflavin administration has been shown to elevate significantly the intracellular pools of FAD and FMN in humans (Hustad et al., 2002) . Highdose riboflavin administration has been used previously, often with great success, to treat patients with conditions caused by genetic defects in a number of flavin-dependent enzymes, including ubiquinone oxidoreductase, pyruvate dehydrogenase, and mitochondrial electron transport complex I. Kmoch et al. (1995) described successful riboflavin treatment of a patient suffering severe epileptic seizures caused by short-chain acyl-CoA dehydrogenase deficiency. Taken together, these studies suggest that the difference between naturally occurring intracellular FMN concentrations and those required to restore function to flavin-deficient CYPOR molecules in patients with certain POR mutations (i.e., Y181D, Y459H, or V492E) could be bridged by therapeutic riboflavin administration, provided genetic predictions were made. 
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